CClinicalTrials.gg
CompletedNCT01276028AIMUpdated Aug 9, 2018

Acupuncture in Menopause

An interventional study of Acupuncture in Vasomotor Symptoms, sponsored by Wake Forest University Health Sciences. Completed at 2 sites in United States. Open to female participants aged 45 Years to 60 Years. Per ClinicalTrials.gov, last updated 2018-08-09.

Sponsored by Wake Forest University Health Sciences · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
209
Allocation
Randomized
Ages
45 Years to 60 Years
Sex
Female
01

Study summary

The primary purpose of this study is to determine the effectiveness of acupuncture for treating vasomotor and other symptoms associated with menopause as acupuncture is generally practiced in the "real world" setting and to obtain a comprehensive assessment of use patterns and symptom relief over time. This study will allow us to determine treatment patterns recommended by practicing acupuncturists, adherence to these treatments, and the effectiveness of different treatment patterns for reducing hot flashes. Results of this study will provide meaningful information to women in terms of number and frequency of acupuncture treatments likely to be needed to reduce hot flashes.

02

Conditions studied

  • Vasomotor Symptoms

Keywords

  • Acupuncture
  • Hot Flashes
  • Menopause
  • Vasomotor Symptoms
03

In context

Lead sponsor

Wake Forest University Health Sciences is the lead sponsor of 1,320 studies on the registry; 199 are open to participants now.

Of its 323 completed or terminated interventional studies of FDA-regulated products, 243 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years to 60 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Inclusion criteria

  • Women experiencing on average 4 Hot Flashes a day
  • Women aged 45-60
  • Peri or Post menopausal Women (No periods for at least 3 months)

Exclusion criteria

Exclusion Criteria:

  • Women who have initiated CAM or non-CAM treatments for hot flashes in the last 4 weeks
  • Women who have changed their dose of a CAM or non-CAM treatments for hot flashes in the last 4 weeks
  • Women who have initiated antidepressants in the last 3 months
  • Women who have changed their dose of an antidepressant in the last 3 months
  • Women who have had acupuncture in the last 4 weeks
  • Women who have received acupuncture from one of the study acupuncturists in the last 6 months will be excluded from the study
  • Women who describe their health as fair or poor are excluded from the study
  • Women who have a diagnosis of Hemophilia
  • Relatives and Co-Workers of the treating acupuncturists
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
209 participants (actual)

Study arms

  • Experimental
    Acupuncture

    This group will start acupuncture treatments within 3 weeks of consent and continue to receive up to 20 treatments over a six month period. The number of treatments will be jointly determined by the participant and the acupuncturist.

    Procedure: Acupuncture

  • Other
    Waitlist

    This group of participants will be asked to wait 6 months and will then be allowed to receive acupuncture.

    Procedure: Acupuncture

Interventions

  • ProcedureAcupuncture

    For the Acupuncture group: Women will be eligible to receive from 1 to 20 treatments over a six month period. These women will receive an initial evaluation by a acupuncturist and will be given a Traditional Chinese Medicine (TCM) diagnosis as well as a recommended treatment schedule which they can then negotiate. Women in the waitlist group will not receive any acupuncture for 6 months. At the end of the 6 month period the participants will be allowed to begin the acupuncture treatments.

06

What researchers measure

Primary outcomes

  1. Subjective Hot Flashes

    Hot Flashes will be monitored via daily diary. This diary will be filled out daily for the first six months (post randomization) of the study and then 1 week per month for the remaining 6 months of the study.

    Time frame: Up to 14 months

Secondary outcomes

  1. Objective Hot Flashes

    Objective hot flashes measured by skin conductance

    Time frame: 3 days

  2. Other Symptoms

    Time frame: Up to 14 months

  3. Quality of Life

    Measures your quality of life over the last week

    Time frame: Up to 58 weeks

07

Study locations

2 sites
  • Chapel Hill Doctors
    Chapel Hill, North Carolina, United States
  • Wake Forest University Baptist Medical Center
    Winston-Salem, North Carolina 27157, United States
08

References and documents

Publications

  • Avis NE, Coeytaux RR, Isom S, Prevette K, Morgan T. Acupuncture in Menopause (AIM) study: a pragmatic, randomized controlled trial. Menopause. 2016 Jun;23(6):626-37. doi: 10.1097/GME.0000000000000597. PubMed 27023860 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 9, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01276028
Lead sponsor
Wake Forest University Health Sciences
Collaborators
National Institutes of Health (NIH)
Responsible party
Sponsor
First posted
Jan 13, 2011
Start date
Apr 2011
Primary completion
Jul 2014
Completion
Jul 2014
Last update
Aug 9, 2018

Study contacts

Nancy Avis, PhD
principal investigator · Wake Forest University Health Sciences

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion